These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 33775753)
1. Evaluation of transduced dendritic cells expressing HIV-1 p24-Nef antigens in HIV-specific cytotoxic T cells induction as a therapeutic candidate vaccine. Sadat Larijani M; Ramezani A; Mashhadi Abolghasem Shirazi M; Bolhassani A; Pouriayevali MH; Shahbazi S; Sadat SM Virus Res; 2021 Jun; 298():198403. PubMed ID: 33775753 [TBL] [Abstract][Full Text] [Related]
2. In Silico Design and Immunologic Evaluation of HIV-1 p24-Nef Fusion Protein to Approach a Therapeutic Vaccine Candidate. Larijani MS; Sadat SM; Bolhassani A; Pouriayevali MH; Bahramali G; Ramezani A Curr HIV Res; 2018; 16(5):322-337. PubMed ID: 30605062 [TBL] [Abstract][Full Text] [Related]
3. Production of Recombinant HIV-1 p24-Nef Protein in Two Forms as Potential Candidate Vaccines in Three Vehicles. Larijani MS; Pouriayevali MH; Sadat SM; Ramezani A Curr Drug Deliv; 2020; 17(5):387-395. PubMed ID: 32183667 [TBL] [Abstract][Full Text] [Related]
4. HIV-1 p24-nef DNA Vaccine Plus Protein Boost Expands T-Cell Responses in BALB/c. Larijani MS; Sadat SM; Bolhassani A; Khodaie A; Pouriayevali MH; Ramezani A Curr Drug Deliv; 2021; 18(7):1014-1021. PubMed ID: 33388019 [TBL] [Abstract][Full Text] [Related]
5. In vivo delivery of a multiepitope peptide and Nef protein using novel cell-penetrating peptides for development of HIV-1 vaccine candidate. Davoodi S; Bolhassani A; Namazi F Biotechnol Lett; 2021 Mar; 43(3):547-559. PubMed ID: 33386500 [TBL] [Abstract][Full Text] [Related]
7. ELISPOT analysis of a new CTL based DNA vaccine for HIV-1 using GM-CSF in DNA prime/peptide boost strategy: GM-CSF induced long-lived memory responses. Mahdavi M; Ebtekar M; Khorram Khorshid HR; Azadmanesh K; Hartoonian C; Hassan ZM Immunol Lett; 2011 Oct; 140(1-2):14-20. PubMed ID: 21679728 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the Efficacy of HIV-1 Nef-Tat-Gp160-p24 Polyepitope Vaccine Candidate with Nef Protein in Different Immunization Strategies. Namazi F; Davoodi S; Bolhassani A Curr Drug Deliv; 2022; 19(1):142-156. PubMed ID: 33655833 [TBL] [Abstract][Full Text] [Related]
9. Naloxone/alum mixture a potent adjuvant for HIV-1 vaccine: induction of cellular and poly-isotypic humoral immune responses. Velashjerdi Farahani S; Reza Aghasadeghi M; Memarnejadian A; Faezi S; Shahosseini Z; Mahdavi M Pathog Glob Health; 2016 Mar; 110(2):39-47. PubMed ID: 26403975 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of a new HIV-1 DNA construct in a BALB/c mouse model. Mahdavi M; Ebtekar M; Mahboudi F; Khorram Khorshid H; Rahbarizadeh F; Azadmanesh K; Darabi H; Pourasgari F; Hassan ZM Iran J Immunol; 2009 Dec; 6(4):163-73. PubMed ID: 20054104 [TBL] [Abstract][Full Text] [Related]
12. HIV-1 Gag p24-Nef fusion peptide induces cellular and humoral immune response in a mouse model. Mahdavi M; Ebtekar M; Azadmanesh K; Khorramkhorshid HR; Rahbarizadeh F; Yazdi MH; Zabihollahi R; Abolhassani M; Hassan ZM Acta Virol; 2010; 54(2):131-6. PubMed ID: 20545443 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of chloroplast-derived HIV-1 p24 and a p24-Nef fusion protein following subcutaneous and oral administration in mice. Gonzalez-Rabade N; McGowan EG; Zhou F; McCabe MS; Bock R; Dix PJ; Gray JC; Ma JK Plant Biotechnol J; 2011 Aug; 9(6):629-38. PubMed ID: 21443546 [TBL] [Abstract][Full Text] [Related]
14. Immune responses against a new HIV-1 p24-gp41/pCAGGS-IL-12 DNA vaccine in Balb/c mice. Roodbari F; Sabahi F; Sarbolouki MN; Barkhordari F; Adeli A; Jamedar A; Mahboudi F Iran J Immunol; 2012 Jun; 9(2):86-97. PubMed ID: 22735796 [TBL] [Abstract][Full Text] [Related]
15. Mucosal Priming with a Recombinant Influenza A Virus-Vectored Vaccine Elicits T-Cell and Antibody Responses to HIV-1 in Mice. Wang J; Shu T; Deng W; Zheng Y; Liao M; Ye X; Han L; He P; Zheng X; Li T; Feng Y; Hu F; Li P; Sun C; Chen L; Li F; Feng L J Virol; 2021 May; 95(12):. PubMed ID: 33789991 [TBL] [Abstract][Full Text] [Related]
17. Small heat shock protein 27: An effective adjuvant for enhancement of HIV-1 Nef antigen-specific immunity. Milani A; Bolhassani A; Shahbazi S; Motevalli F; Sadat SM; Soleymani S Immunol Lett; 2017 Nov; 191():16-22. PubMed ID: 28917624 [TBL] [Abstract][Full Text] [Related]
18. Heterologous prime-boost regimens with a recombinant chimpanzee adenoviral vector and adjuvanted F4 protein elicit polyfunctional HIV-1-specific T-Cell responses in macaques. Lorin C; Vanloubbeeck Y; Baudart S; Ska M; Bayat B; Brauers G; Clarinval G; Donner MN; Marchand M; Koutsoukos M; Mettens P; Cohen J; Voss G PLoS One; 2015; 10(4):e0122835. PubMed ID: 25856308 [TBL] [Abstract][Full Text] [Related]
19. Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization. Tobery TW; Siliciano RF J Exp Med; 1997 Mar; 185(5):909-20. PubMed ID: 9120397 [TBL] [Abstract][Full Text] [Related]
20. Induction of human immunodeficiency virus type-1-specific immunity with a novel gene transport unit (GTU)-MultiHIV DNA vaccine. Blazevic V; Männik A; Malm M; Sikut R; Valtavaara M; Toots U; Ustav M; Krohn K AIDS Res Hum Retroviruses; 2006 Jul; 22(7):667-77. PubMed ID: 16831091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]